MediciBio
MediciBio is a biotechnology company pioneering next-generation LNP platforms and innovative genetic therapeutics. Our proprietary LNP technology integrates versatility, safety, and precision, supporting a wide range of administration routes and therapeutic modalities. The platform drives the development of mRNA-based vaccines, therapeutics, and antibodies, as well as in vivo CAR therapies, and continues to advance through the growth of our internal pipeline and strategic global collaborations, including licensing agreements with partners worldwide.
